Somatostatin analogs
- PMID: 11532069
- DOI: 10.1034/j.1399-3011.2001.00873.x
Somatostatin analogs
Abstract
Somatostatin is a hypothalamic peptide hormone that inhibits the secretion of growth hormone, glucagon, insulin, gastrin and secretin, and also plays a role in neural transmission. Because of its wide range of possible clinical applications hundreds of somatostatin analogs have been synthesized and bioassayed to date. This review gives a historical perspective, summarizing approximately 30 years of research on somatostatin. The main focus is on the structure-activity relationships and conformational studies of the last generation of somatostatin agonists and their selectivity for five somatostatin receptor subtypes. Achievements in the synthesis of nonpeptide somatostatin analogs, as well as the first somatostatin antagonists, are also discussed. Finally, the use of a cyclic somatostatin scaffold to design ligands for other G-protein-coupled receptors, such as opioid and melanocortin receptors, is mentioned.
Similar articles
-
De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.J Med Chem. 2004 Mar 11;47(6):1514-26. doi: 10.1021/jm030452x. J Med Chem. 2004. PMID: 14998337
-
Structure-based search for peptide ligands that cross-react with melanocortin receptors.Pharm Res. 1996 Nov;13(11):1624-30. doi: 10.1023/a:1016424203457. Pharm Res. 1996. PMID: 8956325
-
Somatostatin and its receptor family.Front Neuroendocrinol. 1999 Jul;20(3):157-98. doi: 10.1006/frne.1999.0183. Front Neuroendocrinol. 1999. PMID: 10433861 Review.
-
Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.J Med Chem. 1988 Nov;31(11):2170-7. doi: 10.1021/jm00119a019. J Med Chem. 1988. PMID: 2903246
-
Drug design at peptide receptors: somatostatin receptor ligands.J Mol Neurosci. 2002 Feb-Apr;18(1-2):15-27. doi: 10.1385/JMN:18:1-2:15. J Mol Neurosci. 2002. PMID: 11931345 Review.
Cited by
-
[Somatostatin - an important inhibitor of neuronal activity].Schmerz. 2008 Aug;22(4):409-14. doi: 10.1007/s00482-008-0641-0. Schmerz. 2008. PMID: 18278522 Review. German.
-
In vitro Targetability Validation of Peptide-Functionalized Mesoporous Silica Nanoparticles in the Presence of Serum Proteins.Front Chem. 2020 Nov 13;8:603616. doi: 10.3389/fchem.2020.603616. eCollection 2020. Front Chem. 2020. PMID: 33282845 Free PMC article.
-
Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.J Med Chem. 2009 May 14;52(9):2733-46. doi: 10.1021/jm801314f. J Med Chem. 2009. PMID: 19351180 Free PMC article.
-
Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.J Med Chem. 2008 May 8;51(9):2668-75. doi: 10.1021/jm701444y. Epub 2008 Apr 12. J Med Chem. 2008. PMID: 18410084 Free PMC article.
-
Targeting Somatostatin Receptors By Functionalized Mesoporous Silica Nanoparticles - Are We Striking Home?Nanotheranostics. 2018 Jul 12;2(4):320-346. doi: 10.7150/ntno.23826. eCollection 2018. Nanotheranostics. 2018. PMID: 30148051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources